Close

Add to pipeline

Save Close
You are viewing a limited version of this profile. To access i3's full capabilities.
Evonik
Save
Company logo (jpg or png)
Parent company
Edit alternate names

Short description

Manufacturer of speciality chemicals focusing on health, nutrition, resource efficiency, and globalization markets

Founded in 2007
Founded in

Company type Public Public (EVK.DE)
Company type

Industry Group materials & chemicals

Sector fuels & chemicals

TRL Range 9
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters Germany Essen, Germany
Address
City
State
Zip
Country

Parent Companies Evonik

Website

Updated by Sunena Gupta at on 10/24/2023

Edited by Cleantech Group on 10/22/2024

Traction
  • 1 M&A items
tags
Similar companies
Customers
Save
Add Customer
Date Company
Partnerships
Save
Add Partnership
Date Partner Type
09/21/2023
Remondis Remondis
Evonik and Redmondis will build a plant for recycling PU mattresses based on Evonik's hyrdolyis technology.
View source    
Confirmed by Remondis
Project Development
Delete
Investment Rounds
Save

IPO INFORMATION

Date

04/25/2013

IPO status

Listed

IPO Type

IPO

Amount

$2.6B

Initial shares

Ticker symbol

EVK.DE

Exchange listed

Börse Frankfurt

Prospectus URL

Prospectus

Source URL

Source

Description

Private equity firm CVC Capital Partners and RAG Foundation sold 14.5 per cent of Evonik through a series of pre-listing placements with shares valued at approximately 2billion Euros

Cancel Save
Add Investment
Date Investors Type Amount
01/25/2023 German Federal Ministry of Education and Research German Federal Ministry of Education and Research (1)
Post-money valuation of
Evonik launched the PlasCO2 project which aims to extract synthesis gas from carbon dioxide and hydrogen by means of a plasma reactor. Project participants include the Leibniz Institute for Catalysis (LIKAT), the Leibniz Institute for Plasma Research (INP), and Rafflenbeul Anlagen Bau.
Grant
Delete
Click to add IPO information
Products
Save
Add Product
Product image Name Product status Revenue model Cost metrics
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font